A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir
Condition(s):Infection, Human Immunodeficiency Virus; HIV InfectionsLast Updated:October 28, 2020Completed